inotuzumab ozogamicin

Trials studying inotuzumab ozogamicin

• phase2A Study of Sonrotoclax (BGB-11417) in Children With Relapsed or Refractory Acute Myeloid Leukemia and B-cell Acute Lymphoblastic Leukemianot yet recruitingn=30
• phase2A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALLrecruitingn=100
• phase3A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemiarecruitingn=6,430
• phase2Treatment of Patients With Diffuse Large B Cell Lymphoma Who Are Not Suitable for Anthracycline Containing Chemotherapycompletedn=129
• phase2Inotuzumab Ozogamicin for Children With MRD Positive CD22+ Lymphoblastic Leukemiaterminatedn=5
• phase1Venetoclax Plus Inotuzumab for B-ALLactive not recruitingn=23
• —Besponsa Post Marketing Surveillance Studycompletedn=108
• phase4A Study of Inotuzumab Ozogamicin in Chinese Patients With Relapsed or Refractory Acute Lymphoblastic Leukemiacompletedn=44